GE Healthcare, an integral part of General Electric Company (GE), recently unveiled the next generation pocket-sized ultrasound device with dual probe titled Vscan. The new product combines sector probe with linear probe, making ultrasound scanning faster.
The 2-in-1 probe ultrasound device is the first of its kind and supports various core points with regard to ultrasound procedures. The pocket-sized ultrasound technology provides deep and shallow scans, thereby helping healthcare providers with faster workflow that saves cost and time. The user-friendly device is ultra-portable with excellent image quality to deliver better clinical outcome. This new device optimizes workflow, utilizes resources effectively, increases reporting productivity and improves the accuracy of service in ultrasound procedures.
GE Healthcare provides transformational medical technologies and services to meet the demand for greater access, enhanced quality and affordable healthcare facilities across the globe. The new device is likely to further expand the scope of innovative technologies for patient care and assist healthcare systems with ultrasound diagnostic tools in the fields of cardiology, women’s health and emergency medicine.
General Electric, the parent company, is one of the most diversified technologies and financial service corporations in the world. Its segments include Power & Water, Oil & Gas, Energy Management, Aviation, Healthcare, Transportation, Home & Business Solutions, and GE Capital.
General Electric currently has a Zacks Rank #3 (Hold). Other stocks that look promising and are worth a look now include CLARCOR Inc (CLC), ITT Corporation. (ITT) and Federal Signal Corp (FSS), each carrying a Zacks Rank #2 (Buy).
Read the Full Research Report on GE
Read the Full Research Report on CLC
Read the Full Research Report on FSS
Zacks Investment Research
- Health Care Industry
- GE Healthcare
- General Electric Company